Gonzalez Frank J, Yu Ai-Ming
Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Annu Rev Pharmacol Toxicol. 2006;46:41-64. doi: 10.1146/annurev.pharmtox.45.120403.100007.
Most xenobiotics that enter the body are subjected to metabolism that functions primarily to facilitate their elimination. Metabolism of certain xenobiotics can also result in the production of electrophilic derivatives that can cause cell toxicity and transformation. Many xenobiotics can also activate receptors that in turn induce the expression of genes encoding xenobiotic-metabolizing enzymes and xenobiotic transporters. However, there are marked species differences in the way mammals respond to xenobiotics, which are due in large part to molecular differences in receptors and xenobiotic-metabolizing enzymes. This presents a problem in extrapolating data obtained with rodent model systems to humans. There are also polymorphisms in xenobiotic-metabolizing enzymes that can impact drug therapy and cancer susceptibility. In an effort to generate more reliable in vivo systems to study and predict human response to xenobiotics, humanized mice are under development.
大多数进入人体的外源性物质会经历主要为促进其消除的代谢过程。某些外源性物质的代谢也可能导致亲电衍生物的产生,这些衍生物可引起细胞毒性和转化。许多外源性物质还可激活受体,进而诱导编码外源性物质代谢酶和外源性物质转运蛋白的基因表达。然而,哺乳动物对外源性物质的反应方式存在显著的物种差异,这在很大程度上归因于受体和外源性物质代谢酶的分子差异。这在将从啮齿动物模型系统获得的数据外推至人类时带来了问题。外源性物质代谢酶中也存在多态性,其可影响药物治疗和癌症易感性。为了生成更可靠的体内系统来研究和预测人类对外源性物质的反应,人源化小鼠正在研发中。